Staidson (Beijing) BioPharmaceuticals Co., Ltd.
SHZ: 300204.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wang Chao
- Employees
- 555
- Headquarters
- Beijing, China
- IPO year
- 2011
- Market cap
- CN¥13.3B
- Website
- https://www.staidson.com
Loading 300204…
Loading profile data…Frequently asked questions about 300204
What does Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) do?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of...
Where does 300204.SZ trade?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300204.SZ in?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Staidson (Beijing) BioPharmaceuticals Co., Ltd.?
Wang Chao is the chief executive officer of Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ).
Where is Staidson (Beijing) BioPharmaceuticals Co., Ltd. headquartered?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is headquartered in China.
Does 300204.SZ pay a dividend?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 300204.SZ go public?
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) completed its initial public offering in 2011.